Showing 8,361 - 8,380 results of 9,774 for search 'significantly ((((((larger decrease) OR (linear decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.45s Refine Results
  1. 8361

    Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    “…Introduction<p>The incidence of chronic obstructive pulmonary disease (COPD) and non-alcoholic fatty liver disease (NAFLD) has increased significantly in past decades, posing a significant public health burden. …”
  2. 8362

    Table 1_Effect of compound kushen injection on immune function in patients with colorectal cancer: a systematic review and meta-analysis.docx by Lixin Zhang (55947)

    Published 2025
    “…Chemotherapy and radiotherapy remain cornerstone treatments; however, they often lead to significant immune suppression and an increased risk of infection. …”
  3. 8363

    Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    “…Introduction<p>The incidence of chronic obstructive pulmonary disease (COPD) and non-alcoholic fatty liver disease (NAFLD) has increased significantly in past decades, posing a significant public health burden. …”
  4. 8364

    DataSheet2_α-Mangostin Alleviated Inflammation in Rats With Adjuvant-Induced Arthritis by Disrupting Adipocytes-Mediated Metabolism-Immune Feedback.PDF by Ying-Hao Hu (11087037)

    Published 2025
    “…<p>A previously identified anti-rheumatic compound α-mangostin (MAN) possesses notable metabolism regulatory properties. In this study, we investigated the immune implication of MAN-altered fat metabolism on adjuvant-induced arthritis (AIA) in rats. …”
  5. 8365

    Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    “…Introduction<p>The incidence of chronic obstructive pulmonary disease (COPD) and non-alcoholic fatty liver disease (NAFLD) has increased significantly in past decades, posing a significant public health burden. …”
  6. 8366

    Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    “…Introduction<p>The incidence of chronic obstructive pulmonary disease (COPD) and non-alcoholic fatty liver disease (NAFLD) has increased significantly in past decades, posing a significant public health burden. …”
  7. 8367

    DataSheet1_α-Mangostin Alleviated Inflammation in Rats With Adjuvant-Induced Arthritis by Disrupting Adipocytes-Mediated Metabolism-Immune Feedback.PDF by Ying-Hao Hu (11087037)

    Published 2025
    “…<p>A previously identified anti-rheumatic compound α-mangostin (MAN) possesses notable metabolism regulatory properties. In this study, we investigated the immune implication of MAN-altered fat metabolism on adjuvant-induced arthritis (AIA) in rats. …”
  8. 8368

    Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    “…Introduction<p>The incidence of chronic obstructive pulmonary disease (COPD) and non-alcoholic fatty liver disease (NAFLD) has increased significantly in past decades, posing a significant public health burden. …”
  9. 8369

    Table 2_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    “…Introduction<p>The incidence of chronic obstructive pulmonary disease (COPD) and non-alcoholic fatty liver disease (NAFLD) has increased significantly in past decades, posing a significant public health burden. …”
  10. 8370

    Results for the EPIC bowel subscale and the EORTC QLQ PR25 bowel symptoms scale. by John N. Staffurth (20636565)

    Published 2025
    “…This is also reflected in the mean and median QoL scores (w.r.t. the right-hand axis), which decreased in magnitude with time also.…”
  11. 8371

    Table 2_Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.xlsx by Xianyu Dai (18939514)

    Published 2025
    “…The top 50 drugs were analyzed for annual reporting trends using linear regression. Disproportionality analysis using the reporting odds ratio (ROR) method, with P-values adjusted via Bonferroni correction, identified significant signals, which were then validated against drug labels and re-evaluated using the CVAR database. …”
  12. 8372

    Table 1_Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.docx by Xianyu Dai (18939514)

    Published 2025
    “…The top 50 drugs were analyzed for annual reporting trends using linear regression. Disproportionality analysis using the reporting odds ratio (ROR) method, with P-values adjusted via Bonferroni correction, identified significant signals, which were then validated against drug labels and re-evaluated using the CVAR database. …”
  13. 8373

    Muscles influence motoneuron at NMJ during the critical period, but motoneuron do not affect GluR composition in muscles. by Daniel Sobrido-Cameán (5049743)

    Published 2025
    “…Larvae were reared at the control temperature of 25°C until the late wandering stage, 100 h after larval hatching (ALH). Data are shown with mean ± SEM, ANOVA, **<i>p</i> < 0.001, ****<i>p</i> < 0.00001, ‘ns’ indicates statistical non-significance. …”
  14. 8374

    Table 5_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…</p>Conclusion<p>Statins were associated with decreased mortality in critically ill patients with sepsis. …”
  15. 8375

    Table 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…</p>Conclusion<p>Statins were associated with decreased mortality in critically ill patients with sepsis. …”
  16. 8376

    Table 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…</p>Conclusion<p>Statins were associated with decreased mortality in critically ill patients with sepsis. …”
  17. 8377

    Table 4_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…</p>Conclusion<p>Statins were associated with decreased mortality in critically ill patients with sepsis. …”
  18. 8378

    Table 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…</p>Conclusion<p>Statins were associated with decreased mortality in critically ill patients with sepsis. …”
  19. 8379

    Image 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…</p>Conclusion<p>Statins were associated with decreased mortality in critically ill patients with sepsis. …”
  20. 8380

    Image 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…</p>Conclusion<p>Statins were associated with decreased mortality in critically ill patients with sepsis. …”